SPA
ERAS icon

Sherbrooke Park Advisers’s Erasca ERAS Stock Holding History

Sherbrooke Park Advisers’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$56.9K Buy
+15,300
New +$43K 0.15% 160

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sherbrooke Park Advisers's ERAS Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in Erasca (ERAS) in Q4 2025: 15,300 shares worth $56.9K. The stake represents 0.15% of the portfolio and ranks #160 among its holdings.

154 funds tracked by Wall St. Rank hold ERAS as of Q4 2025.

  • Sherbrooke Park Advisers held 15,300 shares of Erasca worth $56.9K as of Q4 2025.
  • Erasca was a new Sherbrooke Park Advisers position in Q4 2025.
  • Erasca made up 0.15% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #160 holding.
  • 154 funds tracked by Wall St. Rank held Erasca as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.